Applied DNA Sciences Inc.

1.09-0.0550-4.82%Vol 50.45K1Y Perf 1.79%
Oct 3rd, 2023 15:52 DELAYED
BID1.08 ASK1.09
Open1.10 Previous Close1.14
Pre-Market1.16 After-Market-
 0.02 1.75%  - -
Target Price
4.00 
Analyst Rating
Strong Buy 1.00
Potential %
268.66 
Finscreener Ranking
★★★★+     57.77
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★     51.26
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★+     53.18
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
5.16 
Earnings Rating
Strong Buy
Market Cap14.82M 
Earnings Date
10th Aug 2023
Alpha0.01 Standard Deviation0.54
Beta0.59 

Today's Price Range

1.081.20

52W Range

0.97003.20

5 Year PE Ratio Range

-2.20-1.90

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-9.88%
1 Month
-10.94%
3 Months
-12.31%
6 Months
2.70%
1 Year
1.79%
3 Years
-84.59%
5 Years
-98.16%
10 Years
-99.51%

TickerPriceChg.Chg.%
APDN1.09-0.0550-4.82
AAPL172.14-1.6100-0.93
GOOG133.27-1.8962-1.40
MSFT313.06-8.7400-2.72
XOM115.58-0.0500-0.04
WFC38.61-1.0050-2.54
JNJ155.230.08000.05
FB196.640.99000.51
GE107.56-1.2300-1.13
JPM142.61-1.1600-0.81
Financial StrengthValueIndustryS&P 500US Markets
4.40
4.80
0.03
0.15
-2 770.20
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
27.80
-74.20
-67.10
-312.60
-28.81
RevenueValueIndustryS&P 500US Markets
14.00M
1.08
76.10
14.26
Earnings HistoryEstimateReportedSurprise %
Q03 2023-0.24-0.240.00
Q02 2023-0.17-0.20-17.65
Q01 2023-0.33-0.1457.58
Q03 2022-0.36-0.338.33
Q02 2022-0.30-0.286.67
Q01 2022-0.19-0.63-231.58
Q04 2021-0.32-0.49-53.12
Q03 2021-0.24-0.46-91.67
Earnings Per EndEstimateRevision %Trend
9/2023 QR-0.276.90Positive
9/2023 FY-0.861.15Positive
12/2023 QR-0.280.00-
9/2024 FY-0.682.86Positive
Next Report Date-
Estimated EPS Next Report-0.24
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume50.45K
Shares Outstanding13.66K
Shares Float11.50M
Trades Count249
Dollar Volume55.47K
Avg. Volume81.60K
Avg. Weekly Volume39.79K
Avg. Monthly Volume29.15K
Avg. Quarterly Volume175.85K

Applied DNA Sciences Inc. (NASDAQ: APDN) stock closed at 1.14 per share at the end of the most recent trading day (a -5.79% change compared to the prior day closing price) with a volume of 59.58K shares and market capitalization of 14.82M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 61 people. Applied DNA Sciences Inc. CEO is James A. Hayward.

The one-year performance of Applied DNA Sciences Inc. stock is 1.79%, while year-to-date (YTD) performance is -31.33%. APDN stock has a five-year performance of -98.16%. Its 52-week range is between 0.97 and 3.2, which gives APDN stock a 52-week price range ratio of 5.16%

Applied DNA Sciences Inc. currently has a PE ratio of -1.70, a price-to-book (PB) ratio of 1.65, a price-to-sale (PS) ratio of 1.48, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -48.60%, a ROC of -109.24% and a ROE of -75.05%. The company’s profit margin is -28.81%, its EBITDA margin is -67.10%, and its revenue ttm is $14.00 Million , which makes it $1.08 revenue per share.

Of the last four earnings reports from Applied DNA Sciences Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.24 for the next earnings report. Applied DNA Sciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Applied DNA Sciences Inc. is Strong Buy (1), with a target price of $4, which is +268.66% compared to the current price. The earnings rating for Applied DNA Sciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Applied DNA Sciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Applied DNA Sciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 18.77, ATR14 : 0.10, CCI20 : -217.98, Chaikin Money Flow : -0.38, MACD : -0.05, Money Flow Index : 37.14, ROC : -7.32, RSI : 37.30, STOCH (14,3) : 12.50, STOCH RSI : 0.00, UO : 24.45, Williams %R : -87.50), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Applied DNA Sciences Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a provider of DNA-based supply chain, anti-counterfeiting, and anti-theft technology. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. It serves clients in various industries including government/military, security and asset marking, industrial parts, pharmaceuticals, textiles and apparel, and printing and packaging. The company has operational footprints across the United States, Europe, Asia, and others.

CEO: James A. Hayward

Telephone: +1 631 840-8800

Address: 50 Health Sciences Drive, Stony Brook 11790, NY, US

Number of employees: 61

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

62%38%

 

News

Stocktwits